The LANTUS® SoloSTAR® Pen at a Glance
LANTUS® SoloSTAR® is an easy-to-use insulin pen. It comes pre-filled with
LANTUS®, the #1 prescribed insulin‡.
The pen is pre-filled and uses a small, thin needle. An easy-to-use knob lets
you dial in the dose from 1 to 80 units up or down, one unit at a time. And after
injection, the number in the dose window returns to zero.
You can feel even more comfortable about using the LANTUS® SoloSTAR® pen
when you’re more familiar with its parts.
If you use both LANTUS® SoloSTAR® and APIDRA® SoloSTAR®, the pens are designed with features to help tell them apart:
- LANTUS® SoloSTAR® is grey and has a flat, smooth button
- APIDRA® SoloSTAR® is blue and
has a raised, textured button
Indications and Usage for Apidra®
Prescription Apidra® is a rapid-acting insulin for adults with type 2 diabetes
or adults and children (4 years and older) with type 1 diabetes to improve blood
sugar control. Apidra® given by subcutaneous injection is usually used with
a longer-acting insulin. When used as a mealtime insulin, Apidra® should be
given within 15 minutes before or within 20 minutes after starting a meal.
Important Safety Information for Apidra® (insulin glulisine [rDNA origin] injection)
Do not use Apidra® during a low blood sugar reaction (hypoglycemia) or if you
are allergic to any of the ingredients in Apidra.
Please click here for additional Important Safety Information.
Please click here for Full Prescribing Information.
Important Safety Information for Lantus®
Do not take Lantus® if you are allergic to insulin or any of the inactive ingredients
in Lantus®.
You must test your blood sugar levels while using insulin, such as Lantus®.
Do not make any changes to your dose or type of insulin without talking to your
healthcare provider. Any change of insulin should be made cautiously and only under
medical supervision.
Do NOT dilute or mix Lantus® with any other insulin or solution.
It will not work as intended and you may lose blood sugar control, which could be
serious. Lantus® must only be used if the solution is clear and colorless with
no particles visible. Do not share needles, insulin pens or syringes with others.
The most common side effect of insulin, including Lantus®, is low blood
sugar (hypoglycemia), which may be serious. Some people may experience
symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia
may be serious and life threatening. It may cause harm to your heart or brain. Other
possible side effects may include injection site reactions, including changes in
fat tissue at the injection site, and allergic reactions, including itching and
rash. In rare cases, some allergic reactions may be life threatening.
Tell your doctor about other medicines and supplements you are taking because they
can change the way insulin works. Before starting Lantus®, tell your doctor
about all your medical conditions including if you have liver or kidney problems,
are pregnant or planning to become pregnant, or are breast-feeding or planning to
breast-feed.
Lantus® SoloSTAR® is a disposable prefilled insulin pen. Please talk to your healthcare
provider about proper injection technique and follow instructions in the Instruction
Leaflet that accompanies the pen.
Click here for full prescribing information for Lantus®.
Important Safety Information for Apidra® (insulin glulisine [rDNA origin] injection)
Do not use Apidra® during a low blood sugar reaction (hypoglycemia) or if you
are allergic to any of the ingredients in Apidra.
You must test your blood sugar levels while using insulin, such as Apidra®.
Do not make any changes to your dose or type of insulin without talking to your
healthcare provider. Any change of insulin should be made cautiously and only under
medical supervision. Apidra® must only be used if the solution is clear and
colorless with no particles visible. Do not share needles, insulin pens or syringes
with others.
Apidra®, when given by injection under the skin, should not be mixed with insulins
other than NPH. Do not mix Apidra® with any insulin when used in the pump or
for intravenous administration.
The most common side effect of insulin, including Apidra®, is low blood
sugar (hypoglycemia), which may be serious. Some people may experience
symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia
may be serious and life threatening. It may cause harm to your heart or brain. Other
possible side effects may include low blood potassium, injection site reactions,
such as changes in fat tissue at the injection site, and allergic reactions, such
as itching and rash. Less common, but potentially more serious or life-threatening,
is generalized allergy to insulin, including anaphylactic reactions.
Tell your doctor about other medicines and supplements you are taking because they
can change the way insulin works. Before starting Apidra®, tell your doctor
about all your medical conditions including if you have liver or kidney problems,
are pregnant or planning to become pregnant, or are breast-feeding or planning to
breast-feed.
Apidra® SoloSTAR® is a disposable prefilled insulin pen. Please talk to
your healthcare provider about proper injection technique and follow instructions
in the Instruction Leaflet that accompanies the pen.
Click here for Full Prescribing Information for Apidra®.
Important Safety Information for Lantus® SoloSTAR® and Apidra® SoloSTAR®
Lantus® SoloSTAR® pen is grey and Apidra® SoloSTAR® pen is blue.
Each contains a different type of insulin (long-acting vs. rapid-acting). Before
using Lantus® SoloSTAR® or Apidra® SoloSTAR®, carefully examine
the label on the pen to make sure you have the correct insulin.
Click
here for information on Sharps Medical Waste Disposal.
†Needle not included with pen.
‡Based on TRx data from IMS Health, NPA™ monthly database, time period
from May 2003 to March 2010.